ENCELTO
NDC 82958-501, revakinagene taroretcel-lwey, implant, from Neurotech Pharmaceuticals, Inc..
- Product NDC
- 82958-501
- Status
- Listed
- Labeler
- Neurotech Pharmaceuticals, Inc.
- Dosage form
- IMPLANT
- Route
- INTRAVITREAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125798
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82958-501 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- REVAKINAGENE TARORETCEL-LWEY440000 [arb'U]/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82958-501-01 | 82958050101 | 1 CAPSULE in 1 CONTAINER (82958-501-01) / 1 IMPLANT in 1 CAPSULE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/1ae9482a-b478-4e21-9166-b5fd52d3ef9c
Use it
Look up 82958-501 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82958-501 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82958-501. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.